US Patent Litigations are now available. Check here

Explore Onyx Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2662094Apr 17, 2024Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors6